针对乳腺癌的工程采用T细胞疗法:目前的进展,挑战和潜在的挑战
Diego F Chamorro1, Lauren K Somes1, Valentina Hoyos1,2
1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Cancers
|January 11, 2024
概括
工程采用T细胞疗法 (E-ACT) 在乳腺癌治疗方面表现有前途. 本综述详细介绍了CAR和TCRT细胞治疗的进展,挑战以及这种免疫治疗方法的未来方向.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 乳腺癌需要创新的治疗策略.
- 工程采用T细胞疗法 (E-ACT) 是一个有前途的免疫治疗前沿.
- 目前的治疗方法面临局限性,推动了对新方法的需求.
研究的目的:
- 为乳腺癌提供E-ACT的深入分析.
- 探索CAR和TCRT细胞疗法在乳腺癌中的潜力和挑战.
- 审查克服治疗障碍的策略,并讨论临床试验进展.
主要方法:
- 关于工程采用T细胞疗法的综合文献综述.
- 对仿真抗原受体 (CAR) 和T细胞受体 (TCR) T细胞治疗进展的分析.
- 检查乳腺癌免疫治疗中的挑战和解决方案.
主要成果:
- 包括CAR和TCRT细胞疗法在内的E-ACT显示出针对乳腺癌的巨大潜力.
- 关键的挑战包括抗原选择,瘤微环境和T细胞持久性.
- 正在制定提高T细胞功效和克服障碍的策略.
结论:
- E-ACT为乳腺癌提供了一种新且不断发展的治疗途径.
- 解决抗原向和T细胞功能方面的挑战对于临床成功至关重要.
- 目前正在进行的临床试验对于确定E-ACT在乳腺癌治疗中的未来至关重要.
关键词:
卡特 卡特 卡特TCR T T TCR T TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR TCR T乳腺癌 乳腺癌 乳腺癌临床试验是指临床试验中的临床试验.免疫疗法 免疫疗法相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


